Molecular Mechanisms of Mitotane Action in Adrenocortical Cancer Based on In Vitro Studies

Mitotane is the only approved drug for the treatment of advanced adrenocortical carcinoma and is increasingly used for postoperative adjuvant therapy. Mitotane action involves the deregulation of cytochromes P450 enzymes, depolarization of mitochondrial membranes, and accumulation of free cholestero...

Full description

Saved in:
Bibliographic Details
Main Authors: Marco Lo Iacono, Soraya Puglisi, Paola Perotti, Laura Saba, Jessica Petiti, Claudia Giachino, Giuseppe Reimondo, Massimo Terzolo
Format: article
Language:EN
Published: MDPI AG 2021
Subjects:
Online Access:https://doaj.org/article/0fa15dcc1fd64291ae06db3812e4c83f
Tags: Add Tag
No Tags, Be the first to tag this record!